drugset
drugset / Trial / NCT01765023

Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

NCT01765023 ↗

Phase 1 Completed 80 enrolled HK inno.N Corporation
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the pharmacokinetic interactions between atorvastatin and metformin single or co-administered in healthy volunteers

Timeline

Start
2012-10
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.